The proliferative effect of adjuvant tamoxifen on the endometrium can potentially result in endometrial abnormalities, including cancer in postmenopausal women. We conducted a randomized, controlled ...

Women who use Depo-Provera face a higher risk of developing a slow-growing brain tumor, known as a meningioma, while the ...

From Case Western Reserve University School of Medicine and Cleveland Clinic, investigators report that depot medroxyprogesterone acetate use was associated with a higher relative risk of meningioma ...

Reproductive and Sexual Function After Platinum-Based Chemotherapy in Long-Term Ovarian Germ Cell Tumor Survivors: A Gynecologic Oncology Group Study This multicenter prospective study was carried out ...

Lenograstim prevents morbidity from intensive induction chemotherapy in the treatment of inflammatory breast cancer. Between 1984 and 1987 at Flinders Medical Centre, South Australia, 136 ...

Depot-medroxyprogesterone acetate (DMPA) is a hormonal contraceptive especially popular in areas with high prevalence of HIV and other sexually transmitted infections (STI). Although observational ...

In postmenopausal women with coronary artery disease, conjugated equine estrogen with or without continuous administration of medroxyprogesterone acetate has failed to slow the progression of ...

The information provided on this page is intended to serve as a comprehensive resource and should not be a substitute to professional medical advice. If you have concerns it is always best to speak ...

December 14, 2009 — Medroxyprogesterone may be the best available treatment for reducing hot flushes in men undergoing hormone therapy for prostate cancer, according to the results of a double-blind, ...

The FDA approved a label change for the birth control shot depot medroxyprogesterone acetate (Depo-Provera), which now warns about the risk of meningioma, according to a letter posted on the agency ...